# Prospective Study To Assess The Safety And Effectiveness Of Tixel Treatment On Dry Eye Symptoms In Asian Patients

> **NCT04260893** · NA · TERMINATED · sponsor: **Novoxel Ltd.** · enrollment: 44 (actual)

## Conditions studied

- Dry Eye Syndromes
- Dry Eye

## Interventions

- **DEVICE:** Tixel

## Key facts

- **NCT ID:** NCT04260893
- **Lead sponsor:** Novoxel Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-23
- **Primary completion:** 2021-03-13
- **Final completion:** 2021-03-13
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Due to COVID19 adequate study monitoring wasn't possible by the Sponsor
- **Last updated:** 2021-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04260893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04260893, "Prospective Study To Assess The Safety And Effectiveness Of Tixel Treatment On Dry Eye Symptoms In Asian Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04260893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*